FRM
Fox Run Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,900
| Closed | -$1.3M | – | 1217 |
|
|
2024
Q4 | $1.3M | Buy |
+35,900
| New | +$1.3M | 0.24% | 90 |
|
|
2019
Q2 | – | Sell |
-16,034
| Closed | -$562K | – | 617 |
|
|
2019
Q1 | $562K | Buy |
+16,034
| New | +$562K | 0.32% | 82 |
|
|
2018
Q2 | – | Sell |
-16,075
| Closed | -$736K | – | 902 |
|
|
2018
Q1 | $736K | Sell |
16,075
-5,900
| -27% | -$270K | 0.18% | 175 |
|
|
2017
Q4 | $876K | Buy |
+21,975
| New | +$876K | 0.26% | 91 |
|
|
2016
Q1 | – | Sell |
-15,400
| Closed | -$207K | – | 542 |
|
|
2015
Q4 | $207K | Buy |
+15,400
| New | +$207K | 0.16% | 305 |
|